On Invalid Date, Hoth Therapeutics (NASDAQ: HOTH) reported Q3 2023 earnings per share (EPS) of -$0.60, up 70.73% year over year. Total Hoth Therapeutics earnings for the quarter were -$2.09 million. In the same quarter last year, Hoth Therapeutics's earnings per share (EPS) was -$2.05.
As of Q1 2024, Hoth Therapeutics's earnings has grown year over year. Hoth Therapeutics's earnings in the past year totalled -$9.62 million.
What is HOTH's earnings date?
Hoth Therapeutics's earnings date is Invalid Date. Add HOTH to your watchlist to be reminded of HOTH's next earnings announcement.
What was HOTH's revenue last quarter?
On Invalid Date, Hoth Therapeutics (NASDAQ: HOTH) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Hoth Therapeutics's revenue was $0.00.
What was HOTH's revenue growth in the past year?
As of Q1 2024, Hoth Therapeutics's revenue has grown null year over year. Hoth Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.